In 2/3 Generics Cases, Mylan Execs Allowed To Revoke 5th

Дата публикации: 26-10-2026 19:21:24

A Connecticut federal judge carved a different path Friday for two later generic-drug price-fixing cases from state attorneys general, allowing Mylan executives to revoke their previous invocation of the Fifth Amendment unimpeded, after previously allowing the enforcers to challenge that revocation in the first case set for trial.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	5th Circ. Backs FDA, Pharma Cos. In GLP-1 Shortage Fight	0	7.62	27-08-2026
2	Indicted Ex-Housing Boss Pleads 5th In Bond Fracas	0	13.13	13-10-2026
3	Justices poised to protect generics manufacturers from liability for decisions of pharmacists about prescribing their products	0	5	30-04-2026
4	5th Circ. Affirms Defeat Of French Co.'s Bid For Exxon Docs	0	6.33	24-07-2026
5	5th Circ. Backs Ginnie Mae On Reverse Mortgage Liens	0	5.8	13-10-2026
6	Court to consider thorny dispute between manufacturers of medication and its generic substitute	0	5	24-04-2026
7	They Came for Mifepristone. The Abortion Rights Movement Is Ready.	-2	7	07-05-2026
8	Court OKs Antitrust Deal Over Allegheny Health's Expansion	0	5	26-06-2026
9	Supreme Court Reinstates Access to Abortion Pills—For Now	0	7	04-05-2026

Классификация: Экономика. Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 10.76. Источник: www.law360.com.